// App-Quantinova.ai

[AB1186-HPR] : COMPILING AND EVALUATING EVIDENCE-BASED ALGORITHMS FOR THE MONITORING OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING DISEASE MODIFYING ANTIRHEUMATIC DRUGS AND BIOLOGICAL AGENTS

Researchers

Presenter

  • J. Vella

Principal Investigators

  • L. Grech

  • B. Coleiro

  • A. Serracino Inglott

  • L. M. Azzopardi

Medical Centers

  • Rheumatology, Mater Dei Hospital, Msida, Malta

Locations

  • Malta

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Methotrexate

  • HWA-486

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved